DeepCure
PrivateLast Round
Series A
Extension
Apr 11, 2024
Total Funding Raised
$71.6M
Company Overview
DeepCure is a biotechnology company that develops novel small molecule therapeutics for immune and inflammatory diseases. Founded in 2018 by researchers from MIT, the company utilizes a proprietary platform that combines artificial intelligence, physics-based tools, and automated chemical synthesis to identify and develop drugs for historically challenging or 'undruggable' protein targets. The company's platform includes a vast virtual chemical library and an automated robotic wet lab to accelerate the drug discovery process from design to synthesis and analysis. DeepCure is focused on advancing its pipeline of preclinical candidates towards clinical trials, with a particular emphasis on immunology and oncology. The company is venture-backed, having raised significant funding from investors such as Morningside Ventures and IAG Capital Partners.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepCure Comps
Public and private peers based on sector, stage, and business model.
DeepCure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 11, 2024 | ||||
| Series A | Nov 8, 2021 |
Key People
Founding team and executive leadership
DeepCure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IAG Capital Partners | Series A Extension |
| Morningside Ventures | Series A Extension, Series A |
| TLV Partners | Series A Extension, Seed, Series A |
| Benon Group | Series A Extension, Series A |
| The E14 Fund | Series A Extension, Series A |
| Sapir Venture Partners | Series A Extension, Series A, Seed |
DeepCure Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DeepCure's valuation, stock price, and market status.
